Cargando…
LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma
BACKGROUND: Radioresistance-induced local failure, which can result in residual or recurrent tumors, remains one of the major causes of treatment failure in nasopharyngeal carcinoma (NPC). Lipocalin 2 (LCN2) is known to play important roles in cancer initiation, progression, and treatment responses....
Autores principales: | Zhang, Meng-Xia, Wang, Li, Zeng, Lei, Tu, Zi-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885862/ https://www.ncbi.nlm.nih.gov/pubmed/33604288 http://dx.doi.org/10.3389/fonc.2020.605777 |
Ejemplares similares
-
Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma
por: Zhang, Meng-Xia, et al.
Publicado: (2021) -
LCN2 as a Potential Diagnostic Biomarker for Ulcerative Colitis-Associated Carcinogenesis Related to Disease Duration
por: Kou, Fushun, et al.
Publicado: (2022) -
Quantitative Proteomic Analysis Identifies MAPK15 as a Potential Regulator of Radioresistance in Nasopharyngeal Carcinoma Cells
por: Li, Zhanzhan, et al.
Publicado: (2018) -
RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma
por: Qu, Chen, et al.
Publicado: (2017) -
Twist1 promotes radioresistance in nasopharyngeal carcinoma
por: Zhang, Linli, et al.
Publicado: (2016)